QBFM
ARNA

QS Batterymarch Financial Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

QS Batterymarch Financial Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.42M Sell
33,870
-4,435
-12% -$198K 0.04% 475
2014
Q2 		$2.25M Buy
+38,305
New +$2.41M 0.06% 414

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Batterymarch Financial Management's ARNA Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Arena Pharmaceuticals Inc (ARNA) stake by 12% in Q3 2014, selling an estimated $198K and leaving 33,870 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #475.

QS Batterymarch Financial Management first reported a position in ARNA in Q2 2014 and has held it in 2 quarters since. The position peaked at $2.25M in Q2 2014. 121 funds tracked by Wall St. Rank hold ARNA as of Q3 2014.

  • QS Batterymarch Financial Management held 33,870 shares of Arena Pharmaceuticals Inc worth $1.42M as of Q3 2014.
  • QS Batterymarch Financial Management sold 4,435 Arena Pharmaceuticals Inc shares in Q3 2014, an estimated $198K.
  • Arena Pharmaceuticals Inc made up 0.04% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #475 holding.
  • QS Batterymarch Financial Management first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and has held it in 2 quarters since.
  • QS Batterymarch Financial Management's Arena Pharmaceuticals Inc position peaked at $2.25M in Q2 2014.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.